Refametinib R enantiomer
98%
- Product Code: 56138
CAS:
923032-38-6
| Molecular Weight: | 572.34 g./mol | Molecular Formula: | C₁₉H₂₀F₃IN₂O₅S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
Refametinib R enantiomer is primarily utilized in the field of oncology research, particularly in the study and development of targeted cancer therapies. It functions as a selective inhibitor of the MEK enzyme, which plays a critical role in the MAPK/ERK signaling pathway. This pathway is often dysregulated in various cancers, contributing to tumor growth and survival. By inhibiting MEK, this compound helps to suppress the proliferation of cancer cells and induce apoptosis, making it a valuable tool in preclinical studies for understanding cancer mechanisms and evaluating potential therapeutic strategies. Additionally, it is used in combination with other agents to explore synergistic effects in combating resistant cancer types. Its application extends to the development of personalized medicine approaches, where it aids in identifying patient-specific responses to MEK inhibition.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿34,533.00 |
+
-
|
Refametinib R enantiomer
Refametinib R enantiomer is primarily utilized in the field of oncology research, particularly in the study and development of targeted cancer therapies. It functions as a selective inhibitor of the MEK enzyme, which plays a critical role in the MAPK/ERK signaling pathway. This pathway is often dysregulated in various cancers, contributing to tumor growth and survival. By inhibiting MEK, this compound helps to suppress the proliferation of cancer cells and induce apoptosis, making it a valuable tool in preclinical studies for understanding cancer mechanisms and evaluating potential therapeutic strategies. Additionally, it is used in combination with other agents to explore synergistic effects in combating resistant cancer types. Its application extends to the development of personalized medicine approaches, where it aids in identifying patient-specific responses to MEK inhibition.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :